Paul Saladino· MD
so this is a model of metabolic dysfunction aka pathologic insulin resistance that is centered on the adipocytes
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so this is a model of metabolic dysfunction aka pathologic insulin resistance that is centered on the adipocytes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
where does insulin resistance start where does metabolic dysfunction start and they didn't they they kind of skipped over the adipocyte i mean they talked about it a little bit but i think it really starts at the level the fat cell